Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 158 articles:
HTML format



Single Articles


    June 2021
  1. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed     Abstract available


  2. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed     Abstract available


    May 2021
  3. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    PubMed    


    April 2021
  4. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    PubMed     Abstract available


  5. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    PubMed     Abstract available


  6. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed     Abstract available


  7. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    PubMed    


  8. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    PubMed    


    March 2021
  9. YOUNG S, Cam I, Gencturk M
    Reply to "Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome".
    AJR Am J Roentgenol. 2021 Mar 24:W1. doi: 10.2214/AJR.20.24769.
    PubMed    


  10. LUDWIG DR, Fraum TJ, Ballard DH, Narra VR, et al
    Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.
    AJR Am J Roentgenol. 2021 Mar 17:1-11. doi: 10.2214/AJR.20.23099.
    PubMed     Abstract available


  11. MADHUSUDHAN KS, Sharma S
    Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome.
    AJR Am J Roentgenol. 2021 Mar 17:W1. doi: 10.2214/AJR.20.24556.
    PubMed    


  12. SARWAR A, Esparaz AM, Chakrala N, Mangano M, et al
    Efficacy of TIPS Reduction for Refractory Hepatic Encephalopathy, Right Heart Failure, and Liver Dysfunction.
    AJR Am J Roentgenol. 2021 Mar 11:1-6. doi: 10.2214/AJR.19.22497.
    PubMed     Abstract available


  13. LOKKEN RP, Kerlan RK , Jr, Chung YC, Chen YF, et al
    Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Mar 11:1-8. doi: 10.2214/AJR.20.23478.
    PubMed     Abstract available


  14. WANG Y, Liang W
    Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2021;216:W12.
    PubMed    


  15. HOMAYOUNIEH F, Kalra MK
    Reply to "Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions".
    AJR Am J Roentgenol. 2021;216:W13.
    PubMed    


  16. LEE GM, Stowell JT, Pope K, Carter BW, et al
    Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
    AJR Am J Roentgenol. 2021;216:649-658.
    PubMed     Abstract available


    February 2021
  17. WU V, Li MD, Goodwin JS, Wehrenberg-Klee EP, et al
    Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.
    AJR Am J Roentgenol. 2021 Feb 17. doi: 10.2214/AJR.20.25315.
    PubMed     Abstract available


  18. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    PubMed     Abstract available


  19. MARKS RM, Masch WR, Chernyak V
    LI-RADS: Past, Present, and Future, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:295-304.
    PubMed     Abstract available


    January 2021
  20. TORKZAD MR, Riddell AM, Chau I, Cunningham D, et al
    Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 Jan 27:1-8. doi: 10.2214/AJR.20.22854.
    PubMed     Abstract available


  21. LUBNER MG, Graffy PM, Said A, Watson R, et al
    Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.22842.
    PubMed     Abstract available


  22. BUROS C, Furlan A
    Beyond the AJR: "Magnetic Resonance Elastography versus Transient Elastography in the Prediction of Complications after Resection for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25458.
    PubMed    


  23. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Reply to "Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index".
    AJR Am J Roentgenol. 2021;216:W2.
    PubMed    


  24. LIZARAZO DA, Romero J, Gonzalez-Gomez S
    Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index.
    AJR Am J Roentgenol. 2021;216:W1.
    PubMed    


    December 2020
  25. BOYUM JH, Sheedy SP, Graham RP, Olson JT, et al
    Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI.
    AJR Am J Roentgenol. 2020 Dec 23:1-9. doi: 10.2214/AJR.20.22768.
    PubMed     Abstract available


  26. KINNEY TB
    Editorial Comment: A Cautionary Experience with Drug-Eluting Beads Transarterial Chemoembolization for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25284.
    PubMed    


  27. YANG Q, Cai Q, Wen H, Mao Y, et al
    The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    AJR Am J Roentgenol. 2020 Dec 16:1-10. doi: 10.2214/AJR.20.22937.
    PubMed     Abstract available


  28. RENTON M, Kielar A
    Beyond the AJR: "Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications".
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.25188.
    PubMed    


  29. CHENG J, Qiu M, Zhang Y, Hong N, et al
    Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy.
    AJR Am J Roentgenol. 2020;215:1377-1383.
    PubMed     Abstract available


    November 2020
  30. ZHANG L, Sun JH, Ji JS, Zhong BY, et al
    Imaging Changes and Clinical Complications After Drug-Eluting Beads Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    AJR Am J Roentgenol. 2020 Nov 27. doi: 10.2214/AJR.20.24708.
    PubMed     Abstract available


    October 2020
  31. KIM YY, Choi JY, Kim SU, Lee M, et al
    MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
    AJR Am J Roentgenol. 2020 Oct 14:1-9. doi: 10.2214/AJR.20.22802.
    PubMed     Abstract available


  32. STRNAD BS, Ludwig DR, Gilcrease-Garcia B, Fraum TJ, et al
    Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump.
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24437.
    PubMed     Abstract available


  33. KEE-SAMPSON J
    Editorial Comment on "Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis".
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24849.
    PubMed    


    September 2020
  34. NABAVIZADEH N, Jahangiri Y, Rahmani R, Tomozawa Y, et al
    Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis.
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24117.
    PubMed     Abstract available


  35. MICHELL H, Johnston GP, Chopra P, Scriver GM, et al
    Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22469.
    PubMed     Abstract available


  36. PHAM JT, Kalantari J, Ji C, Chang JH, et al
    Quantitative CT Predictors of Portal Venous Intervention in Uncontrolled Variceal Bleeding.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22460.
    PubMed     Abstract available


  37. KIERANS AS, Song C, Gavlin A, Roudenko A, et al
    Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Sep 2:1-8. doi: 10.2214/AJR.20.22772.
    PubMed     Abstract available


  38. ANDREWS JC
    Editorial Comment on "Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24486.
    PubMed    


  39. MONTI L, Salsano M, Candusso M, Avolio AW, et al
    Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging.
    AJR Am J Roentgenol. 2020 Sep 2:1-9. doi: 10.2214/AJR.19.22057.
    PubMed     Abstract available


    August 2020
  40. WEI B, Zhang L, Tong H, Wang Z, et al
    Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding.
    AJR Am J Roentgenol. 2020 Aug 26. doi: 10.2214/AJR.20.23859.
    PubMed     Abstract available


  41. OLSON MC, Venkatesh SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Counterpoint: No, CT/MR is the Way to Go.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24252.
    PubMed    


  42. KAMAYA A, Rodgers SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Point: Yes, Ultrasound Remains First Line.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24382.
    PubMed    


  43. BORRERO R, Valencia S, Triana G
    Are Cutoff Points of Liver Fibrosis in Shear Wave Elastography Really Reliable to Determine Whether Patients Should Undergo Biopsy?
    AJR Am J Roentgenol. 2020;215:W29.
    PubMed    


    July 2020
  44. MANCHEC B, Pham E, Noor M, Pepe J, et al
    Contrast-Enhanced CT May Identify High-Risk Esophageal Varices in Patients With Cirrhosis.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22474.
    PubMed     Abstract available


  45. KIM SW, Kim YR, Choi KH, Cho EY, et al
    Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22041.
    PubMed     Abstract available


    June 2020
  46. CHU HH, Gwon DI, Kim JH, Ko GY, et al
    Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.21669.
    PubMed     Abstract available


    May 2020
  47. YOUNG S, Rostambeigi N, Golzarian J, Lim N, et al
    MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.21726.
    PubMed     Abstract available


  48. SMEREKA P, Doshi AM, Lavelle LP, Shanbhogue K, et al
    New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.22033.
    PubMed     Abstract available


  49. HOMAYOUNIEH F, Singh R, Nitiwarangkul C, Lades F, et al
    Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2020 May 14:1-8. doi: 10.2214/AJR.19.22164.
    PubMed     Abstract available


  50. SARWAR A, Weinstein JL, Novack V, Chakrala N, et al
    Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.
    AJR Am J Roentgenol. 2020 May 6:1-7. doi: 10.2214/AJR.19.21732.
    PubMed     Abstract available


  51. DRESCHER R, Kuhnel C, Seifert P, Guhne F, et al
    Renal and Intestinal Excretion of (90)Y and (166)Ho After Transarterial Radioembolization of Liver Tumors.
    AJR Am J Roentgenol. 2020;214:1158-1164.
    PubMed     Abstract available


    April 2020
  52. YOUNG S, Golzarain J
    Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    AJR Am J Roentgenol. 2020 Apr 7:1-12. doi: 10.2214/AJR.19.22098.
    PubMed     Abstract available


  53. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:786-791.
    PubMed     Abstract available


    March 2020
  54. HUBER AT, Razakamanantsoa L, Lamy J, Giron A, et al
    Multiparametric Differentiation of Idiopathic Dilated Cardiomyopathy With and Without Congestive Heart Failure by Means of Cardiac and Hepatic T1-Weighted MRI Mapping.
    AJR Am J Roentgenol. 2020 Mar 24:1-8. doi: 10.2214/AJR.19.22009.
    PubMed     Abstract available


  55. SCHOOLER GR, Hull NC, Lee EY
    Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.
    AJR Am J Roentgenol. 2020 Mar 17:1-11. doi: 10.2214/AJR.19.22239.
    PubMed     Abstract available


  56. WANG DC, Jang HJ, Kim TK
    Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    AJR Am J Roentgenol. 2020 Mar 17:1-10. doi: 10.2214/AJR.19.21498.
    PubMed     Abstract available


  57. ROMBERG EK, Tang ER, Chandra T, Podberesky DJ, et al
    Applications of Pediatric Body CT Angiography: What Radiologists Need to Know.
    AJR Am J Roentgenol. 2020 Mar 4:1-12. doi: 10.2214/AJR.19.22274.
    PubMed     Abstract available


    January 2020
  58. SHANG S, Cao Q, Han X, Wang Y, et al
    Assessing Liver Hemodynamics in Children With Cholestatic Cirrhosis by Use of Dual-Energy Spectral CT.
    AJR Am J Roentgenol. 2020 Jan 22:1-6. doi: 10.2214/AJR.19.22035.
    PubMed     Abstract available


  59. EL-ALI AM, McCormick A, Thakrar D, Yilmaz S, et al
    Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series.
    AJR Am J Roentgenol. 2020 Jan 22:1-7. doi: 10.2214/AJR.19.22174.
    PubMed     Abstract available


  60. FURLAN A, Tublin ME, Yu L, Chopra KB, et al
    Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:W20-W26.
    PubMed     Abstract available


    December 2019
  61. DEURDULIAN C, Grant EG, Tchelepi H, Latterman PT, et al
    Assessment of Fibrosis in Liver Transplant Recipients: Diagnostic Performance of Shear Wave Elastography (SWE) and Correlation of SWE Findings With Biopsy Results.
    AJR Am J Roentgenol. 2019;213:W264-W271.
    PubMed     Abstract available


    October 2019
  62. RONALD J, Bozdogan E, Zaki IH, Kappus MR, et al
    Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    AJR Am J Roentgenol. 2019 Oct 31:1-6. doi: 10.2214/AJR.19.21655.
    PubMed     Abstract available


  63. LIN M, Lu DS, Duan Y, Liao P, et al
    Cirrhotic Nodule Transformation to Hepatocellular Carcinoma: Natural History and Predictive Biomarkers on Contrast-Enhanced Ultrasound.
    AJR Am J Roentgenol. 2019 Oct 23:1-9. doi: 10.2214/AJR.19.21739.
    PubMed     Abstract available


  64. KOHNO S, Isoda H, Ono A, Furuta A, et al
    Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy.
    AJR Am J Roentgenol. 2019 Oct 23:1-7. doi: 10.2214/AJR.19.21440.
    PubMed     Abstract available


  65. VERNUCCIO F, Godfrey D, Meyer M, Williamson HV, et al
    Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.
    AJR Am J Roentgenol. 2019 Oct 15:1-8. doi: 10.2214/AJR.18.20842.
    PubMed     Abstract available


  66. CONSUL N, Menias CO, Lubner MG, Katabathina VS, et al
    A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    AJR Am J Roentgenol. 2019 Oct 8:1-10. doi: 10.2214/AJR.19.21357.
    PubMed     Abstract available


  67. BROKER MEE, Taimr P, de Vries M, Braun LMM, et al
    Performance of Contrast-Enhanced Sonography Versus MRI With a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia.
    AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.19.21251.
    PubMed     Abstract available


  68. CHUNG JW, Yu JS, Choi JM, Cho ES, et al
    Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.
    AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.18.20797.
    PubMed     Abstract available


    May 2019
  69. CHEN J, Zhou J, Kuang S, Zhang Y, et al
    Liver Imaging Reporting and Data System Category 5 (LI-RADS LR-5): MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-10. doi: 10.2214/AJR.19.21168.
    PubMed     Abstract available


  70. DE HAAS RJ, Lim C, Ricci C, Lahat E, et al
    Local Ablation Does Not Worsen Perioperative Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-8. doi: 10.2214/AJR.18.20993.
    PubMed     Abstract available


  71. BOAS FE, Brown KT, Ziv E, Yarmohammadi H, et al
    Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 May 23:1-7. doi: 10.2214/AJR.18.20846.
    PubMed     Abstract available


  72. HE L, Li H, Dudley JA, Maloney TC, et al
    Machine Learning Prediction of Liver Stiffness Using Clinical and T2-Weighted MRI Radiomic Data.
    AJR Am J Roentgenol. 2019 May 23:1-10. doi: 10.2214/AJR.19.21082.
    PubMed     Abstract available


    April 2019
  73. KIM HO, Yim NY, Kim JK, Kang YJ, et al
    Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes.
    AJR Am J Roentgenol. 2019 Apr 30:1-8. doi: 10.2214/AJR.18.20499.
    PubMed     Abstract available


  74. VERNUCCIO F, Cannella R, Meyer M, Choudhoury KR, et al
    LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.
    AJR Am J Roentgenol. 2019 Apr 30:1-9. doi: 10.2214/AJR.18.20979.
    PubMed     Abstract available


  75. LIMA PH, Fan B, Berube J, Cerny M, et al
    Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2019 Apr 17:1-9. doi: 10.2214/AJR.18.20341.
    PubMed     Abstract available


  76. SMITH AD, Porter KK, Elkassem AA, Sanyal R, et al
    Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis.
    AJR Am J Roentgenol. 2019 Apr 11:1-13. doi: 10.2214/AJR.19.21144.
    PubMed     Abstract available


  77. ABBASI M, Naderi M
    Methodologic Issues in Prediction of Posthepatectomy Liver Failure.
    AJR Am J Roentgenol. 2019;212:W109.
    PubMed    


  78. KIM DK, Choi JI, Choi MH
    Reply to "Methodologic Issues in Prediction of Posthepatectomy Liver Failure".
    AJR Am J Roentgenol. 2019;212:W110.
    PubMed    


  79. LIANG J, Ma R, Chen H, Zhang D, et al
    Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
    AJR Am J Roentgenol. 2019;212:717-726.
    PubMed     Abstract available


    March 2019
  80. POOLER BD, Hernando D, Reeder SB
    Clinical Implementation of a Focused MRI Protocol for Hepatic Fat and Iron Quantification.
    AJR Am J Roentgenol. 2019 Mar 27:1-6. doi: 10.2214/AJR.18.20947.
    PubMed     Abstract available


  81. WANG L, Liu C, Liu J, Li P, et al
    MRI-Guided Cryoablation of Hepatic Dome Hepatocellular Carcinomas Using 1-T Open High-Field-Strength Scanner.
    AJR Am J Roentgenol. 2019 Mar 12:1-9. doi: 10.2214/AJR.18.19815.
    PubMed     Abstract available


  82. JAVADI S, Patnana M, Elsayes KM
    Reply to "Calcified Liver Lesions and Mimics on CT".
    AJR Am J Roentgenol. 2019;212:W99.
    PubMed    


  83. SHARMA M, Dev M
    Calcified Liver Lesions and Mimics on CT.
    AJR Am J Roentgenol. 2019;212:W98.
    PubMed    


    February 2019
  84. NAKAI H, Arizono S, Isoda H, Togashi K, et al
    Imaging Characteristics of Liver Metastases Overlooked at Contrast-Enhanced CT.
    AJR Am J Roentgenol. 2019 Feb 19:1-6. doi: 10.2214/AJR.18.20526.
    PubMed     Abstract available


    January 2019
  85. SARKAR S, Corwin MT, Olson KA, Stewart SL, et al
    Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic (18)F-FDG PET.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20012.
    PubMed     Abstract available


  86. VERNUCCIO F, Rosenberg MD, Meyer M, Choudhury KR, et al
    Negative Biopsy of Focal Hepatic Lesions: Decision Tree Model for Patient Management.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20268.
    PubMed     Abstract available


  87. SUREKA B, Yadav T, Khera PS
    Differential Diagnoses of Calcified Liver Lesions.
    AJR Am J Roentgenol. 2019;212:W20.
    PubMed    


    December 2018
  88. CANNELLA R, Rangaswamy B, Minervini MI, Borhani AA, et al
    Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    AJR Am J Roentgenol. 2018 Dec 17:1-9. doi: 10.2214/AJR.18.20182.
    PubMed     Abstract available


    November 2018
  89. TADA T, Kumada T, Toyoda H, Kobayashi N, et al
    Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
    AJR Am J Roentgenol. 2018 Nov 26:1-10. doi: 10.2214/AJR.18.20123.
    PubMed     Abstract available


    October 2018
  90. LAWRENCE EM, Pooler BD, Pickhardt PJ
    Opportunistic Screening for Hereditary Hemochromatosis With Unenhanced CT: Determination of an Optimal Liver Attenuation Threshold.
    AJR Am J Roentgenol. 2018 Oct 9:1-6. doi: 10.2214/AJR.18.19690.
    PubMed     Abstract available


  91. FALT T, Soderberg M, Horberg L, Christoffersen C, et al
    Simulated Dose Reduction for Abdominal CT With Filtered Back Projection Technique: Effect on Liver Lesion Detection and Characterization.
    AJR Am J Roentgenol. 2018 Oct 9:1-10. doi: 10.2214/AJR.17.19441.
    PubMed     Abstract available


    September 2018
  92. SHETTY AS, Mittal A, Salter A, Narra VR, et al
    Hepatopancreaticobiliary Imaging Second-Opinion Consultations: Is There Value in the Second Reading?
    AJR Am J Roentgenol. 2018 Sep 24:1-8. doi: 10.2214/AJR.17.19452.
    PubMed     Abstract available


  93. HORVAT N, Rocha MS, Chagas AL, Oliveira BC, et al
    Multimodality Screening of Hepatic Nodules in Patients With Congenital Heart Disease After Fontan Procedure: Role of Ultrasound, ARFI Elastography, CT, and MRI.
    AJR Am J Roentgenol. 2018 Sep 24:1-9. doi: 10.2214/AJR.18.19762.
    PubMed     Abstract available


  94. KIM J, Choi SJ, Lee SH, Lee HY, et al
    Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
    AJR Am J Roentgenol. 2018 Sep 21:1-9. doi: 10.2214/AJR.18.19507.
    PubMed     Abstract available


  95. MARION-AUDIBERT AM, Vullierme MP, Ronot M, Mabrut JY, et al
    Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
    AJR Am J Roentgenol. 2018 Sep 21:W1-W9. doi: 10.2214/AJR.18.19640.
    PubMed     Abstract available


    August 2018
  96. CHIEN A, Wang YL, McWilliams J, Lee E, et al
    Venographic Analysis of Portal Flow After TIPS Predicts Future Shunt Revision.
    AJR Am J Roentgenol. 2018 Aug 7:684-688. doi: 10.2214/AJR.17.19287.
    PubMed     Abstract available


  97. FURLAN A, Brancatelli G, Vilgrain V
    Reply to "Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI".
    AJR Am J Roentgenol. 2018;211:W134.
    PubMed    


  98. UNAL E, Karcaaltincaba M
    Oxaliplatin-Induced Liver Changes on Gadoxetate Disodium-Enhanced Liver MRI.
    AJR Am J Roentgenol. 2018;211:W133.
    PubMed    


    July 2018
  99. PATEL BN, Rosenberg M, Vernuccio F, Ramirez-Giraldo JC, et al
    Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
    AJR Am J Roentgenol. 2018 Jul 24:1-9. doi: 10.2214/AJR.17.19170.
    PubMed     Abstract available


  100. PICKHARDT PJ, Graffy PM, Reeder SB, Hernando D, et al
    Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    AJR Am J Roentgenol. 2018 Jul 17:W1-W7. doi: 10.2214/AJR.17.19391.
    PubMed     Abstract available


  101. KIM DK, Choi JI, Choi MH, Park MY, et al
    Prediction of Posthepatectomy Liver Failure: MRI With Hepatocyte-Specific Contrast Agent Versus Indocyanine Green Clearance Test.
    AJR Am J Roentgenol. 2018 Jul 11:1-8. doi: 10.2214/AJR.17.19206.
    PubMed     Abstract available


  102. ELSAYES KM, Chernyak V, Morshid AI, Tang A, et al
    Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
    AJR Am J Roentgenol. 2018;211:87-96.
    PubMed     Abstract available


    May 2018
  103. JHA RC, Khera SS, Kalaria AD
    Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features.
    AJR Am J Roentgenol. 2018 May 24:1-11. doi: 10.2214/AJR.18.19548.
    PubMed     Abstract available


    April 2018
  104. KITAO A, Matsui O, Yoneda N, Kita R, et al
    Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    AJR Am J Roentgenol. 2018 Apr 30:1-11. doi: 10.2214/AJR.17.19341.
    PubMed     Abstract available


  105. WEINSTEIN JL, Ahmed M
    Percutaneous Ablation for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 27:1-8. doi: 10.2214/AJR.17.18695.
    PubMed     Abstract available


  106. NAUGLER WE
    Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 18:1-2. doi: 10.2214/AJR.17.19392.
    PubMed     Abstract available


  107. PATNANA M, Menias CO, Pickhardt PJ, Elshikh M, et al
    Liver Calcifications and Calcified Liver Masses: Pattern Recognition Approach on CT.
    AJR Am J Roentgenol. 2018 Apr 18:1-11. doi: 10.2214/AJR.18.19704.
    PubMed     Abstract available


  108. KWAN SW, Harris WP, Gold LS, Hebert PL, et al
    Comparative Effectiveness of Transarterial Embolization and Sorafenib for Hepatocellular Carcinoma: A Population-Based Study.
    AJR Am J Roentgenol. 2018 Apr 9:1-7. doi: 10.2214/AJR.17.19094.
    PubMed     Abstract available


  109. ALLEN BC, Ho LM, Jaffe TA, Miller CM, et al
    Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 9:1-7. doi: 10.2214/AJR.17.18981.
    PubMed     Abstract available


  110. NAKAI Y, Gonoi W, Hagiwara A, Nishioka Y, et al
    MRI Detection of Intratumoral Fat in Colorectal Liver Metastases After Preoperative Chemotherapy.
    AJR Am J Roentgenol. 2018 Apr 9:W1-W9. doi: 10.2214/AJR.17.18814.
    PubMed     Abstract available


  111. WALSER EM
    Lollipops.
    AJR Am J Roentgenol. 2018;210:W182.
    PubMed    


    March 2018
  112. SUH CH, Kim KW, Park SH, Lee SS, et al
    Shear Wave Elastography as a Quantitative Biomarker of Clinically Significant Portal Hypertension: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Mar 23:W1-W11. doi: 10.2214/AJR.17.18367.
    PubMed     Abstract available


  113. RAGHAVAN K, Jeffrey RB, Olcott EW
    Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion.
    AJR Am J Roentgenol. 2018;210:W129.
    PubMed    


  114. SEO N, Kim DY, Choi JY
    Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion".
    AJR Am J Roentgenol. 2018;210:W130.
    PubMed    


    February 2018
  115. POULLOS PD, Tseng JJ, Melcher ML, Concepcion W, et al
    Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant.
    AJR Am J Roentgenol. 2018 Feb 22:1-9. doi: 10.2214/AJR.17.18725.
    PubMed     Abstract available


  116. HIROOKA M, Hiraoka A, Ochi H, Kisaka Y, et al
    Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2018 Feb 7:1-8. doi: 10.2214/AJR.17.18177.
    PubMed     Abstract available


    January 2018
  117. GUPTA S, Arellano RS, Gervais DA, Sahani DV, et al
    Assessing the Effect of Weight-Based Protocol Modifications to Lower Dose for CT-Guided Hepatic and Renal Tumor Radiofrequency Ablations.
    AJR Am J Roentgenol. 2018 Jan 11:1-6. doi: 10.2214/AJR.17.17952.
    PubMed     Abstract available


  118. FURLAN A, Brancatelli G, Burgio MD, Grazioli L, et al
    Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI.
    AJR Am J Roentgenol. 2018 Jan 11:1-5. doi: 10.2214/AJR.17.18867.
    PubMed     Abstract available


  119. TUBLIN ME, Blair R, Martin J, Malik S, et al
    Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications.
    AJR Am J Roentgenol. 2018;210:183-188.
    PubMed     Abstract available


    December 2017
  120. CUI J, Smolinski SE, Liu F, Xu D, et al
    Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    AJR Am J Roentgenol. 2017 Dec 20:1-9. doi: 10.2214/AJR.17.18222.
    PubMed     Abstract available


  121. PANG EHT, Chan A, Ho SG, Harris AC, et al
    Contrast-Enhanced Ultrasound of the Liver: Optimizing Technique and Clinical Applications.
    AJR Am J Roentgenol. 2017 Dec 8:1-13. doi: 10.2214/AJR.17.17843.
    PubMed     Abstract available


    November 2017
  122. SUH CH, Kim KW, Park SH, Kim SY, et al
    Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
    AJR Am J Roentgenol. 2017 Nov 1:W1-W7. doi: 10.2214/AJR.17.18300.
    PubMed     Abstract available


  123. PIERCE DB, Johnson GE, Monroe E, Loggers ET, et al
    Safety and Efficacy Outcomes of Embolization in Hepatic Sarcomas.
    AJR Am J Roentgenol. 2017 Nov 1:1-8. doi: 10.2214/AJR.16.17573.
    PubMed     Abstract available


  124. SEMAAN S, Makkar J, Lewis S, Chatterji M, et al
    Imaging of Hepatocellular Carcinoma Response After 90Y Radioembolization.
    AJR Am J Roentgenol. 2017;209:W263-W276.
    PubMed     Abstract available


    October 2017
  125. COSTA AF, Thipphavong S, Arnason T, Stueck AE, et al
    Fat-Containing Liver Lesions on Imaging: Detection and Differential Diagnosis.
    AJR Am J Roentgenol. 2017 Oct 24:1-10. doi: 10.2214/AJR.17.18136.
    PubMed     Abstract available


  126. ABRAMSON RG, Lakomkin N, Hainline A, Kang H, et al
    The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
    AJR Am J Roentgenol. 2017 Oct 24:W1-W7. doi: 10.2214/AJR.17.18249.
    PubMed     Abstract available


  127. DILLMAN JR, Trout AT, Costello EN, Serai SD, et al
    Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
    AJR Am J Roentgenol. 2017 Oct 18:1-9. doi: 10.2214/AJR.17.18446.
    PubMed     Abstract available


  128. CHOI HH, Manning MA, Mehrotra AK, Wagner S, et al
    Primary Hepatic Neoplasms of Vascular Origin: Key Imaging Features and Differential Diagnoses With Radiology-Pathology Correlation.
    AJR Am J Roentgenol. 2017 Oct 12:W1-W10. doi: 10.2214/AJR.17.18100.
    PubMed     Abstract available


  129. CORWIN MT, Lee AY, Fananapazir G, Loehfelm TW, et al
    Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication.
    AJR Am J Roentgenol. 2017 Oct 12:1-6. doi: 10.2214/AJR.17.18416.
    PubMed     Abstract available


  130. KATO A, Nakamoto Y, Ishimori T, Seo S, et al
    Predictability of 99mTc-Galactosyl Human Serum Albumin Scintigraphy for Posthepatectomy Liver Failure.
    AJR Am J Roentgenol. 2017 Oct 12:1-8. doi: 10.2214/AJR.17.18411.
    PubMed     Abstract available


  131. GOMES AS, Monteleone PA, Sayre JW, Finn RS, et al
    Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
    AJR Am J Roentgenol. 2017;209:722-732.
    PubMed     Abstract available


    September 2017
  132. GLAZER DI, Tatli S, Shyn PB, Vangel MG, et al
    Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to Long-Term Outcomes.
    AJR Am J Roentgenol. 2017 Sep 27:1-9. doi: 10.2214/AJR.16.17582.
    PubMed     Abstract available


  133. CAMPO CA, Hernando D, Schubert T, Bookwalter CA, et al
    Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    AJR Am J Roentgenol. 2017;209:592-603.
    PubMed     Abstract available


  134. ISHIKAWA T, Aibe Y, Matsuda T, Iwamoto T, et al
    Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts.
    AJR Am J Roentgenol. 2017;209:W169-W176.
    PubMed     Abstract available


    August 2017
  135. CHEN HJ, Liu PF, Chen QF, Shi HB, et al
    Brain Microstructural Abnormalities in Patients With Cirrhosis Without Overt Hepatic Encephalopathy: A Voxel-Based Diffusion Kurtosis Imaging Study.
    AJR Am J Roentgenol. 2017 Aug 16:1-8. doi: 10.2214/AJR.17.17827.
    PubMed     Abstract available


  136. HAN NY, Park BJ, Yang KS, Kim MJ, et al
    Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
    AJR Am J Roentgenol. 2017 Aug 16:1-7. doi: 10.2214/AJR.16.17528.
    PubMed     Abstract available


  137. PARK HJ, Kim JH, Choi SY, Lee ES, et al
    Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
    AJR Am J Roentgenol. 2017 Aug 16:W1-W10. doi: 10.2214/AJR.16.17398.
    PubMed     Abstract available


  138. LI F, Han J, Han F, Wang JW, et al
    Combined Hepatocellular Cholang iocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    AJR Am J Roentgenol. 2017 Aug 4:1-8. doi: 10.2214/AJR.16.17513.
    PubMed     Abstract available


  139. JADVAR H
    Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.
    AJR Am J Roentgenol. 2017;209:277-288.
    PubMed     Abstract available


  140. SUGITA R, Ito K, Noda Y
    Reply to "Biliopancreatic Reflux Shown on Gadoxetic Acid-Enhanced MRI".
    AJR Am J Roentgenol. 2017;209:W118.
    PubMed    


  141. KARAOSMANOGLU AD, Karcaaltincaba M
    Biliopancreatic Reflux Shown on Gadoxetic Acid-Enhanced MRI.
    AJR Am J Roentgenol. 2017;209:W117.
    PubMed    


    July 2017
  142. SUH CH, Kim KW, Pyo J, Lee J, et al
    Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2017 Jul 25:1-9. doi: 10.2214/AJR.16.17711.
    PubMed     Abstract available


  143. HAIDER SJ, Tarulli M, McNulty NJ, Hoffer EK, et al
    Liver Abscesses: Factors That Influence Outcome of Percutaneous Drainage.
    AJR Am J Roentgenol. 2017;209:205-213.
    PubMed     Abstract available


    June 2017
  144. AN C, Park S, Chung YE, Kim DY, et al
    Curative Resection of Single Primary Hepatic Malignancy: Liver Imaging Reporting and Data System Category LR-M Portends a Worse Prognosis.
    AJR Am J Roentgenol. 2017 Jun 28:1-8. doi: 10.2214/AJR.16.17478.
    PubMed     Abstract available


  145. AHMAD T, Chavhan GB, Avitzur Y, Moineddin R, et al
    Doppler Parameters of the Hepatic Artery as Predictors of Graft Status in Pediatric Liver Transplantation.
    AJR Am J Roentgenol. 2017 Jun 28:1-5. doi: 10.2214/AJR.17.17902.
    PubMed     Abstract available


  146. CORVINO A, Catalano O, Corvino F, Sandomenico F, et al
    Diagnostic Performance and Confidence of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Cystic and Cysticlike Liver Lesions.
    AJR Am J Roentgenol. 2017 Jun 22:W1-W9. doi: 10.2214/AJR.16.17062.
    PubMed     Abstract available


  147. CHOI SH, Kim SY, Lee SS, Shim JH, et al
    Subtraction Images of Gadoxetic Acid-Enhanced MRI: Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2017 Jun 13:1-8. doi: 10.2214/AJR.16.17211.
    PubMed     Abstract available


  148. SEO N, Kim DY, Choi JY
    Cross-Sectional Imaging of Intrahepatic Cholangiocarcinoma: Development, Growth, Spread, and Prognosis.
    AJR Am J Roentgenol. 2017 Jun 1:W1-W12. doi: 10.2214/AJR.16.16923.
    PubMed     Abstract available


  149. CEKIC B, Toslak IE, Sahinturk Y, Cekin AH, et al
    Differentiating Transudative From Exudative Ascites Using Quantitative B-Mode Gray-Scale Ultrasound Histogram.
    AJR Am J Roentgenol. 2017 Jun 1:1-7. doi: 10.2214/AJR.16.16509.
    PubMed     Abstract available


  150. BRAILLON A
    Transarterial Radioembolization for Hepatocellular Carcinoma Is Safe, but Is It Effective?
    AJR Am J Roentgenol. 2017;208:W241.
    PubMed    


    May 2017
  151. DUNPHY M, Pandit-Taskar N, Fox JJ, Kemeny N, et al
    The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.
    AJR Am J Roentgenol. 2017 May 24:1-5. doi: 10.2214/AJR.16.17560.
    PubMed     Abstract available


  152. ALIBERTI C, Carandina R, Sarti D, Mulazzani L, et al
    Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2017 May 24:1-5. doi: 10.2214/AJR.16.17477.
    PubMed     Abstract available


  153. TIPIRNENI-SAJJA A, Krafft AJ, McCarville MB, Loeffler RB, et al
    Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2* MRI.
    AJR Am J Roentgenol. 2017 May 15:1-8. doi: 10.2214/AJR.16.17183.
    PubMed     Abstract available


  154. KELLER EJ, Kulik L, Stankovic Z, Lewandowski RJ, et al
    JOURNAL CLUB: Four-Dimensional Flow MRI-Based Splenic Flow Index for Predicting Cirrhosis-Associated Hypersplenism.
    AJR Am J Roentgenol. 2017 May 2:1-9. doi: 10.2214/AJR.16.17620.
    PubMed     Abstract available


    March 2017
  155. COVEY AM, Hussain SM
    Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings.
    AJR Am J Roentgenol. 2017 Mar 28:1-10. doi: 10.2214/AJR.17.17799.
    PubMed     Abstract available


  156. PAIGE JS, Bernstein GS, Heba E, Costa EA, et al
    A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2017 Mar 7:W1-W10. doi: 10.2214/AJR.16.16726.
    PubMed     Abstract available


  157. SARWAR A, Esparaz AM, Tapper EB, Brook OR, et al
    Comparison of Vascular Plugs and Pushable Coils for Variceal Embolization After TIPS.
    AJR Am J Roentgenol. 2017;208:650-655.
    PubMed     Abstract available


    August 2016
  158. CANELLAS R, Mehrkhani F, Patino M, Kambadakone A, et al
    Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units).
    AJR Am J Roentgenol. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: